-
1
-
-
0034860476
-
NSW Neonatal Intensive Care Unit Study Group. Outcome of very premature infants with necrotising enterocolitis cared for in centers with or without on site surgical facilities
-
M. Loh, and D.A. Osborn NSW Neonatal Intensive Care Unit Study Group. Outcome of very premature infants with necrotising enterocolitis cared for in centers with or without on site surgical facilities Arch Dis Child Fetal Neonatal Ed 85 2001 F114 F118
-
(2001)
Arch Dis Child Fetal Neonatal Ed
, vol.85
-
-
Loh, M.1
Osborn, D.A.2
-
2
-
-
0029817252
-
Liver hemorrhage during laparotomy in patients with necrotizing enterocolitis
-
W.E. Vanderkolk, P. Kurz, J. Daniels, and B.W. Warner Liver hemorrhage during laparotomy in patients with necrotizing enterocolitis J Pediatr Surg 31 1996 1063 1067
-
(1996)
J Pediatr Surg
, vol.31
, pp. 1063-1067
-
-
Vanderkolk, W.E.1
Kurz, P.2
Daniels, J.3
Warner, B.W.4
-
3
-
-
0036429702
-
Severe liver haemorrhage during laparotomy in very low birthweight infants
-
W. Pumberger, C. Kohlhauser, M. Mayer, and G. Pomberger Severe liver haemorrhage during laparotomy in very low birthweight infants Acta Paediatr 91 2002 1260 1267
-
(2002)
Acta Paediatr
, vol.91
, pp. 1260-1267
-
-
Pumberger, W.1
Kohlhauser, C.2
Mayer, M.3
Pomberger, G.4
-
4
-
-
0345598029
-
Recombinant FVIIa for intractable hemorrhage: More questions than answers
-
N.S. Key Recombinant FVIIa for intractable hemorrhage: more questions than answers Transfusion 43 2003 1649 1651
-
(2003)
Transfusion
, vol.43
, pp. 1649-1651
-
-
Key, N.S.1
-
5
-
-
0036303030
-
The use of recombinant activated Factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy
-
A. Chuansumrit, P. Nuntnarumit, C. Okascharoen, S. Teeraratkul, S. Suwansingh, and S. Supapannachart The use of recombinant activated Factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy Pediatrics 110 2002 169 171
-
(2002)
Pediatrics
, vol.110
, pp. 169-171
-
-
Chuansumrit, A.1
Nuntnarumit, P.2
Okascharoen, C.3
Teeraratkul, S.4
Suwansingh, S.5
Supapannachart, S.6
-
6
-
-
0036902441
-
Life threatening hemorrhage in neonates: Management with recombinant activated factor VII
-
A. Veldman, D. Fischer, B. Voigt, P.A. Beyer, R. Schlosser, and A. Allendorf Life threatening hemorrhage in neonates: management with recombinant activated factor VII Int Care Med 28 2002 1635 1637
-
(2002)
Int Care Med
, vol.28
, pp. 1635-1637
-
-
Veldman, A.1
Fischer, D.2
Voigt, B.3
Beyer, P.A.4
Schlosser, R.5
Allendorf, A.6
-
7
-
-
2542493016
-
Use of recombinant factor VIIa in infants with severe coagulopathy
-
M.J. Fontaine, J. Lazarchick, S. Taylor, and D. Annibale Use of recombinant factor VIIa in infants with severe coagulopathy J Perinatol 24 2004 310 311
-
(2004)
J Perinatol
, vol.24
, pp. 310-311
-
-
Fontaine, M.J.1
Lazarchick, J.2
Taylor, S.3
Annibale, D.4
-
8
-
-
1242351780
-
Refractory bleeding following major surgery of a giant sacrococcygeal tearoom in a premature infant: Successful use of recombinant factor VIIa
-
M. Grist, R. Ranch, R. Carbon, T. Habit, and M. Halfback Refractory bleeding following major surgery of a giant sacrococcygeal tearoom in a premature infant: successful use of recombinant factor VIIa Euro J Pediatr 163 2004 118 119
-
(2004)
Euro J Pediatr
, vol.163
, pp. 118-119
-
-
Grist, M.1
Ranch, R.2
Carbon, R.3
Habit, T.4
Halfback, M.5
-
9
-
-
0034005045
-
Clinical efficacy and recovery levels of recombinant FVIIa (Novoseven) in the treatment of intracranial hemorrhage in severe neonatal FVII deficiency
-
W.Y. Wong, W.C. Huang, R. Miller, K. McGinty, and J.K. Whisnant Clinical efficacy and recovery levels of recombinant FVIIa (Novoseven) in the treatment of intracranial hemorrhage in severe neonatal FVII deficiency Haemophilia 6 2000 50 54
-
(2000)
Haemophilia
, vol.6
, pp. 50-54
-
-
Wong, W.Y.1
Huang, W.C.2
Miller, R.3
McGinty, K.4
Whisnant, J.K.5
-
10
-
-
3042836547
-
Management of coagulopathy with recombinant factor VIIa in a neonate with echovirus type 7
-
J. Tancabelic, and S.E. Huan Management of coagulopathy with recombinant factor VIIa in a neonate with echovirus type 7 Pediatr Blood Cancer 43 2004 170 176
-
(2004)
Pediatr Blood Cancer
, vol.43
, pp. 170-176
-
-
Tancabelic, J.1
Huan, S.E.2
-
11
-
-
0842277799
-
Dosing with recombinant factor VIIa based on current evidence
-
U. Hedner Dosing with recombinant factor VIIa based on current evidence Semin Hematol 41 Suppl 1 2004 35 39
-
(2004)
Semin Hematol
, vol.41
, Issue.1 SUPPL.
, pp. 35-39
-
-
Hedner, U.1
-
12
-
-
0346921344
-
Mechanism of action of recombinant factor VIIa
-
T. Lisman, and P.H.G. De Groot Mechanism of action of recombinant factor VIIa J Thromb Haemost 1 2003 1138 1139
-
(2003)
J Thromb Haemost
, vol.1
, pp. 1138-1139
-
-
Lisman, T.1
De Groot, P.H.G.2
-
13
-
-
4043184093
-
Pharmacokinetics of activated recombinant coagulation factor VII (Novoseven) in children vs. adults with haemophilia a
-
A. Villar, S. Aronis, M. Morfini, E. Santagostino, G. Auerswald, and H.F. Thomsen Pharmacokinetics of activated recombinant coagulation factor VII (Novoseven) in children vs. adults with haemophilia A Haemophilia 10 2004 352 359
-
(2004)
Haemophilia
, vol.10
, pp. 352-359
-
-
Villar, A.1
Aronis, S.2
Morfini, M.3
Santagostino, E.4
Auerswald, G.5
Thomsen, H.F.6
|